Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%

October 22, 2026 · 10:12 pm 1 sources

Image: Ars Technica

Coverage

Coverage

• Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%
  Ars Technica · October 22, 2026 22:12
  Markers released top-line results today after previously reporting the trial succeeded.